苏州德龙激光股份有限公司 2025 年第三季度报告 证券代码：688170 证券简称：德龙激光 苏州德龙激光股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是√否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | 非经常性损益项目 | 本期金额 | 年初至报告期 末金额 | 说明 | | --- | --- | --- | --- | | 非流动性资产处置损益，包括已计提资产减值准备的冲 | -45,710.49 | -52,885.33 | | | 销部分 | | | | | 计入当期损益的政府补助，但与公司正常经营业务密切 | | | | | 相关、符合 ...

浙江大胜达包装股份有限公司 2025 年第三季度报告 证券代码：603687 证券简称：大胜达 浙江大胜达包装股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期比上 | | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 年同期增减变 | 年初至报告期末 | 比上年同期增减 | | | | 动幅度(%) | | 变动幅度(%) | | 营业收入 | 561,992,516.68 | 5.85 | 1,587,302,761.9 ...

Financial Performance - The company's operating revenue for Q3 2025 was ¥345,664,992.29, representing a year-on-year increase of 32.55%[4] - The total profit for Q3 2025 was a loss of ¥1,785,561.06, while the net profit attributable to shareholders was a loss of ¥3,732,443.30[4] - Year-to-date revenue as of Q3 2025 was ¥1,176,682,888.68, showing a decline of 4.09% compared to the same period last year[4] - The company experienced a decrease in net profit attributable to shareholders for the year-to-date period, primarily due to a decline in overall operating revenue and increased asset impairment losses[9] - Net profit for the first three quarters of 2025 was a loss of CNY 37,479,740.52, compared to a loss of CNY 29,116,284.23 in 2024, representing a 28.7% increase in losses[19] - Earnings per share for the first three quarters of 2025 was CNY -0.09, compared to CNY -0.07 in the same period of 2024[20] - The company reported a total comprehensive loss of CNY 38,121,312.60 for the first three quarters of 2025, compared to a loss of CNY 30,502,059.20 in 2024[20] Cash Flow - The net cash flow from operating activities for the year-to-date period was a negative ¥12,179,913.08, reflecting a decrease of 103.10%[5] - Cash inflow from operating activities for the first three quarters of 2025 was CNY 1,495,270,455.61, a decrease of 22.5% from CNY 1,928,225,260.17 in 2024[22] - Cash received from sales of goods and services was CNY 1,324,693,130.29, down from CNY 1,429,344,168.04 in the previous year[22] - The net cash flow from operating activities was -$12.18 million, a significant decrease compared to $393.16 million in the previous period[23] - The company reported a total cash outflow from operating activities of $1.51 billion, slightly lower than $1.54 billion in the previous period[23] Assets and Liabilities - The total assets at the end of Q3 2025 were ¥2,594,850,868.54, down 5.61% from the end of the previous year[5] - The equity attributable to shareholders at the end of Q3 2025 was ¥2,447,228,432.65, a decrease of 1.49% from the previous year[5] - As of September 30, 2025, the company's total assets amounted to CNY 2,594,850,868.54, a decrease from CNY 2,748,938,027.69 as of December 31, 2024[14] - The company's cash and cash equivalents decreased to CNY 649,081,257.74 from CNY 833,765,764.39 year-over-year[14] - The total current liabilities decreased significantly to CNY 151,409,506.24 from CNY 261,185,420.31 in the previous year[16] - The company's inventory decreased to CNY 352,367,990.61 from CNY 435,666,051.57 year-over-year[15] - The company's long-term equity investments decreased to CNY 6,796,287.94 from CNY 8,979,311.89 year-over-year[15] - The company's total non-current liabilities decreased to CNY 4,410,593.60 from CNY 10,600,526.09 year-over-year[16] - The company's accounts receivable decreased to CNY 41,703,459.69 from CNY 51,312,892.08 year-over-year[14] - The company reported a significant increase in other receivables, totaling CNY 152,275,088.44 compared to CNY 164,834,832.97 in the previous year[15] Strategic Developments - The company's self-owned brand and general agency business grew rapidly, accounting for nearly 15% of total revenue in the first three quarters of 2025[13] - The company entered into a strategic partnership with ENDOCARE, becoming the brand's general agent in mainland China, responsible for brand promotion and market operations[13] Research and Development - Research and development expenses for the first three quarters of 2025 were CNY 16,574,954.98, slightly down from CNY 17,715,212.00 in 2024[18] Other Income - The company reported non-recurring gains of ¥19,605,893.77 for the current period, with government subsidies contributing ¥23,677,467.71[7] - Other income for the first three quarters of 2025 was CNY 24,620,305.36, an increase from CNY 19,342,129.12 in 2024[18]

合肥颀中科技股份有限公司 2025 年第三季度报告 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 608,843,952.69 | 21.42 | 1,604,604,873.92 | 11.80 | | 利润总额 | 98,303,105.16 | 24.35 | 211,043,205.11 | -21.15 | | 归属于上市公司股东的 净利润 | 85,348,767.25 | 28.58 | 184,540,169.65 | -19.20 | | 归属于上市公司股东的 扣除非经常性损益的净 利润 | 80,954,805.57 ...

悦康药业集团股份有限公司2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 1 / 15 证券代码：688658 证券简称：悦康药业 悦康药业集团股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 单位：元 币种：人民币 项目 本报告期 本报告期比 上年同期增 减变动幅度 (%) 年初至报告期末 年初至报告期 末比上年同期 增减变动幅度 (%) 营业收入 591,724,095.10 -43.20 1,759,106,131.97 -41.20 利润总额 -57,556,783.12 -152.45 -164,811,303.27 -166.38 归属于上 ...

Financial Performance - The company's operating revenue for the third quarter was ¥756,747,488.74, a decrease of 35.41% compared to the same period last year[5]. - The total profit for the quarter was -¥171,036,227.96, with a year-to-date total profit of -¥59,034,465.76[5]. - The net profit attributable to shareholders was -¥290,804,357.47 for the quarter, and -¥565,017,516.92 year-to-date[5]. - Total operating revenue for the first three quarters of 2025 was CNY 2,496,335,302.26, a decrease of 42.6% compared to CNY 4,370,434,178.01 in the same period of 2024[20]. - Net profit for the first three quarters of 2025 was a loss of CNY 296,834,576.43, compared to a loss of CNY 271,622,667.03 in the same period of 2024[21]. - The total comprehensive income for the first three quarters of 2025 was a loss of CNY 352,649,184.46, compared to a loss of CNY 284,453,716.16 in the same period of 2024[22]. Cash Flow - The net cash flow from operating activities was ¥130,502,127.93, a decrease of 58.44% year-to-date[5]. - Net cash flow from operating activities for the first three quarters of 2025 was $353.16 million, down 58.5% from $849.72 million in 2024[25]. - Cash outflow from operating activities totaled $2.41 billion in the first three quarters of 2025, compared to $2.96 billion in 2024, indicating a decrease of 17.5%[25]. - Cash inflow from investment activities in the first three quarters of 2025 was $586.37 million, an increase of 58.0% compared to $370.95 million in 2024[25]. - Net cash flow from investment activities for the first three quarters of 2025 was $510.99 million, contrasting with a slight outflow of $1.17 million in 2024[25]. - Total cash inflow from financing activities in the first three quarters of 2025 was approximately $6.60 billion, an increase of 21.1% from $5.45 billion in 2024[25]. - Net cash flow from financing activities for the first three quarters of 2025 was negative at $1.93 billion, compared to a negative $944.08 million in 2024[25]. - The ending cash and cash equivalents balance as of the end of the third quarter of 2025 was approximately $3.57 billion, down from $4.74 billion at the end of the same period in 2024[25]. Assets and Liabilities - The total assets at the end of the reporting period were ¥17,260,174,045.38, down 11.73% from the end of the previous year[6]. - The total liabilities decreased from CNY 16,110,137,980.69 in the previous year to CNY 14,166,438,094.73, reflecting a reduction of approximately 12.0%[18]. - The total equity attributable to shareholders decreased from CNY 1,164,654,868.63 to CNY 572,523,170.52, a decline of about 50.8%[18]. - Cash and cash equivalents are reported at ¥3,891,215,895.34, down from ¥5,064,954,792.24 in the previous year[16]. - Inventory stands at ¥7,806,478,874.46, compared to ¥8,193,988,147.39 in the previous year[16]. - The company has reported a short-term loan of ¥5,632,533,433.53, an increase from ¥4,959,389,702.40 in the previous year[17]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 58,131[12]. - The largest shareholder, Zhuhai Investment Holdings Co., Ltd., holds 847,339,780 shares, accounting for 44.95% of total shares[12]. Strategic Focus - The significant decrease in operating revenue was primarily due to reduced revenue from real estate project completions[9]. - The net cash flow from operating activities was negatively impacted by a decrease in sales collections[9]. - The company plans to transfer 100% equity of Zhuhai Gree Real Estate Co., Ltd. to Zhuhai Tojie Holdings Co., Ltd., marking a significant asset restructuring[15]. - The company is focusing on de-emphasizing real estate and concentrating on duty-free and consumer business sectors[15]. Earnings Per Share - The basic and diluted earnings per share for the quarter were both -¥0.15[6]. - Basic and diluted earnings per share for the first three quarters of 2025 were both CNY -0.30, compared to CNY -0.31 in the same period of 2024[22]. Research and Development - Research and development expenses for the first three quarters of 2025 were CNY 2,177,117.33, a decrease from CNY 2,658,286.88 in 2024[20]. Investment Performance - The company reported an investment loss of CNY 31,087,984.57 in the first three quarters of 2025, compared to a gain of CNY 25,935,773.97 in the same period of 2024[20]. - Other comprehensive income after tax for the first three quarters of 2025 was a loss of CNY 55,814,608.03, compared to a loss of CNY 12,831,049.13 in 2024[21]. Accounting Standards - The company will not apply new accounting standards starting from 2025[26].

盛德鑫泰新材料股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 证券代码：300881 证券简称：盛德鑫泰 公告编号：2025-047 盛德鑫泰新材料股份有限公司 2025 年第三季度报告 □是 否 1 盛德鑫泰新材料股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 834,679,481.71 | 31.02% | 2 ...

Financial Performance - The company's revenue for Q3 2025 was ¥77,638,032.47, a decrease of 27.31% compared to the same period last year[5] - The net profit attributable to shareholders was -¥39,436,426.38, representing a decline of 564.27% year-on-year[5] - The basic earnings per share were -¥0.44, down 588.89% from the previous year[5] - Total operating revenue for the third quarter reached ¥302,820,599.84, an increase of 5.8% compared to ¥286,982,201.72 in the previous period[33] - Net profit for the third quarter was a loss of ¥36,324,957.80, compared to a profit of ¥19,605,210.06 in the same period last year[34] - The total comprehensive income for the current period is -36,335,559.75, compared to 19,605,210.06 in the previous period, indicating a significant decline[35] - The basic and diluted earnings per share for the current period are both -0.41, down from 0.23 in the previous period[35] Assets and Liabilities - Total assets at the end of the reporting period were ¥966,274,090.64, an increase of 2.50% from the end of the previous year[5] - The company's total assets as of September 30, 2025, were ¥966,274,090.64, an increase from ¥942,749,138.84 at the beginning of the period[30] - Current liabilities rose to ¥226,518,681.51, up from ¥164,564,122.78 at the start of the period, reflecting a significant increase in short-term borrowings[30] - The total equity attributable to shareholders decreased to ¥733,234,336.06 from ¥769,132,196.45, reflecting a decline in retained earnings[31] Cash Flow - The company's cash flow from operating activities showed a net outflow of -¥33,712,303.19, a decrease of 38.88% compared to the previous year[5] - Cash inflows from operating activities totaled 315,816,227.84, an increase from 242,285,716.94 in the previous period[37] - Cash outflows from operating activities amounted to 349,528,531.03, compared to 266,560,303.42 in the previous period, resulting in a net cash flow from operating activities of -33,712,303.19[38] - Cash inflows from investing activities were 261,358,641.85, up from 133,281,217.80 in the previous period[38] - Cash outflows from investing activities increased to 467,063,407.87 from 268,607,655.27 in the previous period, leading to a net cash flow from investing activities of -205,704,766.02[38] - Cash inflows from financing activities reached 100,040,000.00, compared to 30,540,000.00 in the previous period[38] - Cash outflows from financing activities decreased to 31,570,467.52 from 37,627,917.11 in the previous period, resulting in a net cash flow from financing activities of 68,469,532.48[38] - The ending cash and cash equivalents balance is 276,081,971.83, compared to 185,697,752.31 in the previous period[38] Shareholder Information - The total number of common shareholders at the end of the reporting period is 6,343[14] - The largest shareholder, Shanshui Bide Group, holds 39.17% of shares, totaling 36,512,000 shares[14] - The second-largest shareholder, Sun Hu, owns 20.43% of shares, amounting to 19,040,000 shares[14] - The total number of restricted shares at the beginning of the period was 42,125,000, with 39,860,000 shares released during the period[17] - The number of shares held by the top ten shareholders does not include shares lent through margin trading[15] - The total number of shares held by the top ten unrestricted shareholders is 66,000,000[15] - The company has no preferred shareholders or related changes in preferred stock ownership[16] Stock Option Incentive Plan - The company has implemented a stock option incentive plan for 2025, granting a total of 2.705 million stock options, which is 2.99% of the company's total share capital[18] - The first grant under the incentive plan consists of 2.345 million stock options, representing 86.69% of the total options granted[18] - The company has reserved 360,000 stock options for future grants, which is 0.4% of the total share capital[18] - The company approved the 2025 Stock Option Incentive Plan, granting 2.345 million stock options at an exercise price of 43.81 CNY per option to 78 incentive recipients[20] - As of September 15, 2025, all 39 eligible incentive recipients exercised a total of 2.71488 million shares, increasing the total share capital from 90.496 million shares to 93.21088 million shares[23] - The exercise price for the 2024 Stock Option Incentive Plan was adjusted from 29.68 CNY to 21.2 CNY per share, with the number of options increased from 3.8784 million to 5.42976 million[22] - The company's controlling shareholder's stake was diluted from 74.85% to 72.94% due to the stock option exercise, a change that touched a 1% integer multiple[24] Strategic Investments and Business Operations - The company's inventory increased by 176.72% to ¥9,139,214.66, attributed to the expansion of EPC business scale[9] - The company reported a 33.56% increase in operating costs, totaling ¥185,210,266.57, mainly due to higher design personnel costs and new EPC business costs[10] - Cash received from sales increased by 33.15% to ¥309,524,114.96, driven by improved collection rates[12] - The company made strategic investments totaling ¥460,000,000.00, a 76.92% increase compared to the previous year, indicating a focus on external strategic investments[12] - Research and development expenses for the quarter were ¥25,762,975.92, slightly up from ¥25,504,637.44 in the previous period, indicating continued investment in innovation[33] Fundraising and Financial Management - The company approved adjustments to the internal investment structure and extended the expected completion date for several fundraising projects to August 31, 2028[25] - A new special account for raised funds was established at CITIC Bank for the storage, use, and management of funds related to fundraising projects[26] - The company appointed a new sponsor representative to ensure ongoing supervision of the IPO process, with the supervision period ending on December 31, 2024[28] Audit Status - The financial report for the third quarter has not been audited[40]

迪阿股份有限公司 2025 年第三季度报告 证券代码：301177 证券简称：迪阿股份 公告编号：2025-058 迪阿股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 迪阿股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比 | | --- | --- | --- | --- | --- | | | | 增减 | | 上年同期增减 | | 营业收入（元） | 370,315,196.21 | 11.17% | 1,156,382,612.03 ...

万邦德医药控股集团股份有限公司 2025 年第三季度报告 证券代码：002082 证券简称：万邦德 公告编号：2025-059 万邦德医药控股集团股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 万邦德医药控股集团股份有限公司 2025 年第三季度报告 一、主要财务数据 （一）主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入（元） | 439,154,394.07 | ...